Hepatitis B elimination requires expanded vaccination, screening, treatment, and education, Helen Nde, MPH, said.
Helen Nde, MPH
Advertisement
Helen Nde, MPH, is a data and project management consultant at Center for Disease Analysis Foundation.
Articles by Helen Nde, MPH
Early findings from the CDAF-Relink program highlight gaps in re-engagement, outreach barriers, and opportunities to reconnect patients to care.
Hepatitis B re-engagement efforts are underreported in lower-resource settings, highlighting gaps in care and the need for greater action.
Re-engagement rates for patients with hepatitis B lost to follow-up range from 2% to 100% globally, with proximity to patients driving the best outcomes.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Multiagonists Outpace Older GLP-1 Drugs for Weight Loss
2
Evolocumab Cuts Death Risk for a First Heart Attack or Stroke
3
Physical Function Views Differ Between Older AML Patients, Clinicians
4
Cardiac Risks of COVID-19 Vaccine vs Infection: Eman Toraih, MD, PhD
5